Characteristics and retreatment of HCV DAA failure patients: Real-life experience

被引:0
|
作者
Ruiz, I. [1 ]
Fourati, S. [1 ]
Varaut, A. [1 ]
Giovanna, S. [1 ]
Francois, M. [1 ]
Wlassow, M. [1 ]
Poiteau, L. [1 ]
Donati, F. [1 ]
Soulier, A. [1 ]
Stephane, C. [1 ]
Mallat, A. [1 ]
Pawlotsky, J. -M. [1 ]
Hezode, C. [1 ]
机构
[1] CHU Henri Mondor, AP HP, Creteil, France
关键词
D O I
10.1016/S0168-8278(18)30772-4
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
THU-332
引用
收藏
页码:S277 / S278
页数:2
相关论文
共 50 条
  • [21] Real-Life Experience with Perampanel in 36 Patients
    Tagliafico, L.
    Di Biasio, F.
    Fancellu, R.
    Serrati, C.
    Ferrari, A.
    EPILEPSIA, 2018, 59 : S271 - S272
  • [22] Real-life experience of guselkumab in patients with psoriasis
    Snast, Igor
    Sherman, Shany
    Holzman, Roie
    Hodak, Emmilia
    Pavlovsky, Lev
    DERMATOLOGIC THERAPY, 2020, 33 (06)
  • [23] DAA-based treatment for HIV-HCV-coinfected patients: analysis of factors of sustained virological response in a real-life study
    Alessio, Loredana
    Onorato, Lorenzo
    Sangiovanni, Vincenzo
    Borrelli, Francesco
    Manzillo, Elio
    Esposito, Vincenzo
    Simeone, Filomena
    Martini, Salvatore
    Capoluongo, Nicolina
    Leone, Sebastiano
    Di Filippo, Giovanni
    D'Abbraccio, Maurizio
    Aprea, Lucia
    Megna, Angelo Salomone
    Milano, Eugenio
    Rizzo, Viviana
    Saracino, Annalisa
    Coppola, Nicola
    ANTIVIRAL THERAPY, 2020, 25 (04) : 193 - 201
  • [24] Renal safety in 3264 HCV patients treated with DAA-based regimens: Results from a large Italian real-life study
    D'Ambrosio, Roberta
    Pasulo, Luisa
    Giorgini, Alessia
    Spinetti, Angiola
    Messina, Emanuela
    Fanetti, Ilaria
    Puoti, Massimo
    Aghemo, Alessio
    Vigano, Paolo
    Vincij, Maria
    Menzaghi, Barbara
    Lombardi, Andrea
    Pan, Angelo
    Pigozzi, Marie Graciella
    Grossi, Paolo
    Lazzaroni, Sergio
    Spinelli, Ombretta
    Invernizzi, Pietro
    Maggiolo, Franco
    Terreni, Natalia
    Monforte, Antonella D'Arminio
    Del Poggio, Paolo
    Taddei, Maria Teresa
    Colombo, Silvia
    Pozzoni, Pietro
    Molteni, Chiara
    Brocchieri, Alessandra
    Bhoori, Sherrie
    Buscarini, Elisabetta
    Centenaro, Riccardo
    Mendeni, Monia
    Colombo, Alberto Eraldo
    Di Marco, Mariella
    Dionigi, Elena
    Bella, Daniele
    Borghi, Marta
    Zuin, Massimo
    Zaltron, Serena
    Noventa, Franco
    Annalisa, De Silvestri
    Lampertico, Pietro
    Fagiuoli, Stefano
    DIGESTIVE AND LIVER DISEASE, 2020, 52 (02) : 190 - 198
  • [25] SOFOSBUVIR CONTAINING REGIMES TO PATIENTS WITH HCV GENOTYPE 3 INFECTION. A SCANDINAVIAN REAL-LIFE EXPERIENCE
    Dalgard, O.
    Weis, N.
    Noraberg, G.
    Isaksen, K.
    Oevrehus, A.
    Skjaer, M. Skalshoj
    Weiland, O.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S287 - S288
  • [26] The Italian compassionate use of sofosbuvir in HCV patients waitlisted for liver transplantation: A national real-life experience
    Martini, Silvia
    Donato, Maria Francesca
    Mazzarelli, Chiara
    Rendina, Maria
    Visco-Comandini, Ubaldo
    Fili, Daniela
    Gianstefani, Alice
    Fagiuoli, Stefano
    Melazzini, Mario
    Montilla, Simona
    Pani, Luca
    Petraglia, Sandra
    Russo, Pierluigi
    Trotta, Maria Paola
    Carrai, Paola
    Caraceni, Paolo
    LIVER INTERNATIONAL, 2018, 38 (04) : 733 - 741
  • [27] Efficacy and safety of direct-acting antivirals for HCV in patients with extrahepatic malignancies: real-life experience
    Mira Atef
    Rasha Eletreby
    Mohamed Abdallah
    Rasha Salama
    Wafaa Elakel
    Mohamed Hassany
    Wael Abdel-Razek
    Yehia El Shazly
    Wahid Doss
    Gamal Esmat
    Egyptian Liver Journal, 12
  • [28] Efficacy and safety of direct-acting antivirals for HCV in patients with extrahepatic malignancies: real-life experience
    Atef, Mira
    Eletreby, Rasha
    Abdallah, Mohamed
    Salama, Rasha
    Elakel, Wafaa
    Hassany, Mohamed
    Abdel-Razek, Wael
    El Shazly, Yehia
    Doss, Wahid
    Esmat, Gamal
    EGYPTIAN LIVER JOURNAL, 2022, 12 (01)
  • [29] TREATMENT FAILURE TO FIRST-LINE DIRECT ANTIVIRAL (DAA) IN HCV-RELATED ADVANCED LIVER DISEASE: AN ITALIAN REAL-LIFE URBAN SETTING
    Di Paolo, D.
    Rossi, P.
    Lenci, I.
    Milana, M.
    Masetti, C.
    Santopaolo, F.
    Lionetti, R.
    D'Offizi, G.
    Pellicelli, A.
    Fondacaro, L.
    Siciliano, M.
    Gerardi, V.
    Chiesara, F.
    Moretti, A.
    Ceccherini-Silberstein, F.
    Cento, V.
    Perno, C. F.
    Angelico, M.
    DIGESTIVE AND LIVER DISEASE, 2016, 48 : E2 - E3
  • [30] Resistance-guided retreatment of HCV infected patients with a previous failure to an NS5A inhibitor-containing regimen: Italian real life experience
    Di Maio, Velia Chiara
    Aragri, Marianna
    Masetti, Chiara
    Paolucci, Stefania
    Bruzzone, Bianca
    Degasperi, Elisabetta
    Barbaliscia, Silvia
    Pollicino, Teresa
    Minichini, Carmine
    Calvaruso, Vincenza
    Rendina, Maria Grazia
    Cento, Valeria
    Teti, Elisabetta
    Micheli, Valeria
    Ghisetti, Valeria
    Polilli, Ennio
    Palitti, Valeria Pace
    Landonio, Simona
    Lenci, Ilaria
    Donnarumma, Laura
    Nicolini, Laura Ambra
    Bertoli, Ada
    Pasquazzi, Caterina
    Callegaro, Maria Paola
    Morisco, Filomena
    Cenderrello, Giovanni
    Marenco, Simona
    Gulminetti, Roberto
    Novati, Stefano
    Andreone, Pietro
    Ciancio, Alessia
    Sangiovanni, Vincenzo
    Cuomo, Nunzia
    Morsica, Giulia
    Borghi, Vanni
    Maida, Ivana Rita
    Brunetto, Maurizia
    Cozzolongo, Raffaele
    De Santis, Adriano
    Lichtner, Miriam
    Babudieri, Sergio
    Taliani, Gloria
    Santantonio, Teresa
    Paternoster, Claudio
    Ganga, Roberto
    Puoti, Massimo
    Rizzardini, Giuliano
    Pellicelli, Adriano
    Lampertico, Pietro
    Parruti, Giustino
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E218 - E219